| Barry F Gleason, MD | |
|
22 Bramhall St, Portland, ME 04102-3134 | |
| (207) 662-2526 | |
| Not Available |
| Full Name | Barry F Gleason |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 22 Bramhall St, Portland, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841362043 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD15977 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barry F Gleason, MD 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 482-7800 | Barry F Gleason, MD 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 662-2526 |
News Archive
Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers funded by the National Institutes of Health have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1.
A new study has shown that anticardiolipin antibodies are associated with the novel coronavirus infection or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19.
This remarkable publication focuses on the importance of genetics in mental retardation, investigating the extent to which molecular diagnostic capability and the understanding of genetic causes have improved over recent years. As a result, clinical evaluation and diagnostic laboratory practice are now undergoing an unprecedented period of change.
Zacks Equity Research initiated research coverage on CardioGenics Holdings Inc. with a six-month target price of $1.22 per share.
The Huntington Study Group (HSG), under the leadership of Samuel Frank, MD, Principal Investigator, (Boston University School of Medicine) and Claudia Testa, MD, PhD, co-Principal Investigator (Virginia Commonwealth University), is conducting a clinical trial with a formulation of the novel drug SD-809 in the treatment of HD the United States and Canada.
› Verified 5 days ago
David Edward Landry, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 | |
Francis Altman, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 144 State St, Anesthesia Department, Portland, ME 04101 Phone: 207-879-3385 | |
Dylan Wingfield, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-478-6024 | |
Dr. Frederick Craig Littlejohn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1945 Congress St Ste 103, Portland, ME 04102 Phone: 207-835-8116 | |
Christopher James Beeler, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-0111 | |
Charles F Adams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 | |
Jeffrey Morse, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 144 State St, Anesthesia Department, Portland, ME 04101 Phone: 207-879-3385 |